Clinical Trials Logo

Treatment Naive AML clinical trials

View clinical trials related to Treatment Naive AML.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02203773 Terminated - Clinical trials for Acute Myelogenous Leukemia

Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Start date: October 6, 2014
Phase: Phase 1
Study type: Interventional

This is a Phase 1b, open-label, non-randomized, multicenter study to evaluate the safety and pharmacokinetics of orally administered venetoclax (ABT-199) combined with decitabine or azacitidine and the preliminary efficacy of these combinations. In addition, there is a drug-drug interaction (DDI) sub-study only at a single site, to assess the pharmacokinetics and safety of venetoclax (ABT-199) in combination with posaconazole.